Efficacy and safety of indacaterol 150 mcg once-daily in COPD: a double-blind, randomised, 12-week study
BMC Pulmonary Medicine, 03/10/2010
Free full text
Feldman G et al. – Indacaterol 150 mcg o.d. provided clinically significant and sustained bronchodilation, reduced rescue medication use, and had a safety and tolerability profile similar to placebo.







